Nesiritide acutely increases pulmonary and systemic levels of nitric oxide and cGMP in pulmonary hypertension patients

被引:0
|
作者
Michaels, AD [1 ]
Harmon, CT [1 ]
Johengen, M [1 ]
Fineman, J [1 ]
Chatterjee, K [1 ]
De Marco, T [1 ]
机构
[1] Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2587
引用
收藏
页码:555 / 556
页数:2
相关论文
共 50 条
  • [21] Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement
    Malerba, Mario
    Radaeli, Alessandro
    Ragnoli, Beatrice
    Airo, Paolo
    Corradi, Massimo
    Ponticiello, Antonio
    Zambruni, Alberto
    Grassi, Vittorio
    CHEST, 2007, 132 (02) : 575 - 580
  • [22] Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep
    Deruelle, P
    Grover, TR
    Abman, SH
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 289 (05) : L798 - L806
  • [23] Effects of inhaled nitric oxide (INO) on pulmonary and systemic cytokines in newborns with persistent pulmonary hypertension (PPHN)
    Vento, G
    Matassa, PG
    Ameglio, F
    Capoluongo, E
    Zecca, E
    Tortorolo, L
    Papacci, P
    Maggio, L
    Ferrara, MT
    Martelli, M
    Romagnoli, C
    PEDIATRIC RESEARCH, 2003, 53 (04) : 511A - 512A
  • [24] Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
    Hajian, Bita
    De Backer, Jan
    Vos, Wim
    Van Holsbeke, Cedric
    Ferreira, Francisca
    Quinn, Deborah A.
    Hufkens, Annemie
    Claes, Rita
    De Backer, Wilfried
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1533 - 1541
  • [25] Nitric oxide production is preserved in patients with primary pulmonary hypertension
    Djaballah, K
    DinhXuan, A
    Humbert, M
    Simmoneau, G
    Weir, EK
    Archer, SL
    CIRCULATION, 1997, 96 (08) : 2391 - 2391
  • [26] Association of nitric oxide dose and methemoglobin levels in patients with congenital heart disease and pulmonary hypertension
    Riddle, EM
    Feltes, TF
    Rosen, K
    Fraley, JK
    Mott, AR
    Kovalchin, JP
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04): : 442 - +
  • [27] Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
    Tang, Haiyang
    Vanderpool, Rebecca R.
    Wang, Jian
    Yuan, Jason X. -J.
    PULMONARY CIRCULATION, 2017, 7 (03) : 569 - 571
  • [28] Exhaled nitric oxide in systemic sclerosis: Relationships with lung involvement and pulmonary hypertension
    Rolla, G
    Colagrande, P
    Scappaticci, E
    Chiavassa, G
    Dutto, L
    Cannizzo, S
    Bucca, C
    Morello, M
    Bergerone, S
    Bardini, D
    Zaccagna, A
    Puiatti, P
    Fava, C
    Cortese, C
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (07) : 1693 - 1698
  • [29] Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension
    Michaels, AD
    Chatterjee, K
    De Marco, T
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : 425 - 431
  • [30] Right ventricle function during inhaled nitric oxide test in systemic sclerosis patients with pulmonary hypertension
    Plazak, W.
    Podolec, P.
    Zabinska-Plazak, E.
    Musial, J.
    Tracz, W.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 219 - 220